MY ACCOUNT | NEWSLETTER |

Current evidence for non-pharmaceutical, non-surgical treatments of canine osteoarthritis


For many of the management options outlined in this review, there is a need for larger scale clinical trials.

OA is a progressive, degenerative disease which can cause inflammation within the joints and poses a risk to canine health and welfare (Summers et al. 2019). There is no cure for OA, but there are now many management options aimed at reducing pain and improving mobility in affected dogs. A multimodal approach to the treatment of canine OA, including both pharmaceutical and non- pharmaceutical therapies has been proposed to be most effective in treating this disease (Fox 2016, Pye et al. 2022). With more complementary therapies becoming available to veterinary practitioners, this review has aimed to address commonly used non- surgical, non-pharmaceutical treatment options for canine OA and highlight current evidence gaps.

Weight management has shown to be beneficial in the management of OA but can take time to see results (Burkholder & Hulse 2000, Mlacnik et al. 2006, Marshall et al. 2010). Therefore, it is important that owners are kept engaged with regular visits for weight checks and pursue an appropriate weight loss programme for their dogs. There is evidence for the use of certain nutraceuticals such as omega- 3 fatty acids. Acupuncture, PBMT and ECSWT may also play a role in reducing the clinical signs of OA, although further research is needed to gain a greater understanding of their efficacy (Moreau et al. 2003, Boileau et al. 2009, Souza et al. 2016, de Oliveira Reusing et al. 2021). There is a lack of randomised controlled trials investigating the efficacy of different physiotherapy programmes, both land-based and aquatic, which would aid the development of best practice guidelines for canine OA treatment.


Author: C Pye, N Clark, N Bruniges, M Peffers, E Comerford

Source: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13670


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

NC State Student Creates Coloring Book to Help Children Picture Possibilities in Veterinary Medicine

Like0
Dislike0

UltiMed Expands Syringe Portfolio with Launch of UltiCare® VetRx General Syringes

Like0
Dislike0

Innovations in animal health: artificial intelligence-enhanced hematocrit analysis for rapid anemia detection in small ruminants

Like0
Dislike0

Drug dose and drug choice: Optimizing medical therapy for veterinary cancer

Like0
Dislike0

The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top